The case for & against
Bull & Bear analysis
Bullish
Crane Company (NYSE: CR) is a diversified manufacturer providing a wide range of engineered solutions across aerospace, electronics, and process flow technologies sectors. The company is well-positioned in fast-growing markets, focusing on innovation to meet the evolving demands of its military and commercial customers. Crane's strategic initiatives, particularly its recent acquisitions, aim to enhance its technological capabilities and market competitiveness in key growth areas.
Bull says
- ↑Q2 sales of $725M up 26% YoY; core sales +5% led by aerospace.
- ↑Backlog near $1.3B, +11% FX-neutral YoY, boosting demand visibility.
- ↑EPS guidance raised by $0.20 to $6.85–$7.05; acquisitions add ~$0.20/share.
- ↑Net leverage ~1.2x after $190M debt repayment, signaling strong balance sheet.
- ↑Favorable interest-rate sensitivity; modest growth and positive revision factors.
- ↑Analysts expect higher defense spending to drive future earnings.
Bear says
- ↓Integration risks from deals could dilute segment margins short term.
- ↓Process Flow Tech sales growing flat to low single digits amid weak chemical markets.
- ↓Inflation and tariff headwinds may compress operating profit margins.
- ↓Dependence on defense contracts exposes revenue to government budget swings.
- ↓Elevated leverage and weak liquidity metrics raise financial stress concerns.
- ↓Negative earnings and dividend yields suggest limited investor return potential.
Investment themes with CR
Infrastructure Development↓ -1.13%
DE · HWM · TT
Earnings Call · Q2 2025 · Mgmt. Guidance
Updated 08-14-2026bullish
Transcript signals
Bull points
- RotorStroke has a very strong share position in the boiling water reactor installed nuclear facilities, which provides a mature position and opportunities for replacement and new nuclear plant restarts.
- In all three legs, I think they're very well positioned to take advantage of replacement, restarts, and new technologies that come in the nuclear space.
- strong resilient aftermarket. We see technology that's incredibly sticky, hard to replace. We see many opportunities to adjust the model and be more efficient and reduce costs. So we're very confident on that path to significantly improve the margins in the first few years, certainly hitting that five-year 10% ROI or beating.
Bear points
- As expected and as we anticipated coming out of Q1, no really surprise on the chemical market, We're seeing some softness, and we included that in our guidance. Europe in particular has been the softest, with other regions holding in there better. Customers have, as you know, lowered CapEx expenditures this year.
- We continue to expect operating margin to be lower in the second half due to a less favorable mix between commercial OEM and the aftermarket.
Read full transcript analysis ›